1-8 of 8
Stacy Moulder
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract C016: Oxidative phosphorylation is a metabolic vulnerability in chemotherapy resistant triple negative breast cancer

Kurt Evans, Stacy Moulder, Erkan Yuca, Stephen Scott, Natalia Paez Arango, Maryam Shariati, Christopher P Vellano, Turcin Saridogan, Xiaofeng Zheng, Ana Maria Gonzalez-Angulo, Ming Zhao, Xiaoping Su, Coya Tapia, Ken Chen, Argun Akcakanat, Charles M Perou, Bora Lim, Debu Tripathy, Timothy A Yap, Maria E Di Francesco, Giulio Draetta, Philip Jones, Joe Marszalek, Funda Meric-Bernstam
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (12_Supplement): C016.
https://doi.org/10.1158/1535-7163.TARG-19-C016
Published: 01 December 2019
View article titled, Abstract C016: Oxidative phosphorylation is a metabolic vulnerability in chemotherapy resistant triple negative breast cancer
Journal Articles

Triple-Negative Breast Cancer Patients Treated at MD Anderson Cancer Center in Phase I Trials: Improved Outcomes with Combination Chemotherapy and Targeted Agents

Prasanth Ganesan, Stacy Moulder, J. Jack Lee, Filip Janku, Vicente Valero, Ralph G. Zinner, Aung Naing, Siqing Fu, Apostolia M. Tsimberidou, David Hong, Bettzy Stephen, Philip Stephens, Roman Yelensky, Funda Meric-Bernstam, Razelle Kurzrock, Jennifer J. Wheler
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2014) 13 (12): 3175–3184.
https://doi.org/10.1158/1535-7163.MCT-14-0358
Published: 04 December 2014
View article titled, Triple-Negative Breast Cancer Patients Treated at MD Anderson Cancer Center in Phase I Trials: Improved Outcomes with Combination Chemotherapy and Targeted Agents
Open the PDF for Triple-Negative Breast Cancer Patients Treated at MD Anderson Cancer Center in Phase I Trials: Improved Outcomes with Combination Chemotherapy and Targeted Agents in another window
Includes: Supplementary data
Journal Articles

Abstract A212: Next generation sequencing (NGS) in 57 patients with advanced or metastatic breast cancer: Identification of unique genomic profiles and correlation with response.

Jennifer J. Wheler, Barbara A. Parker, Jack Lee, Roman Yelensky, Stacy Moulder, Apostolia M. Tsimberidou, Filip Janku, Johnique T. Atkins, Ralph Zinner, Richard Q. Schwab, Maria Schwaederle, Vivek Subbiah, Siqing Fu, Philip J. Stephens, Razelle Kurzrock
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): A212.
https://doi.org/10.1158/1535-7163.TARG-13-A212
Published: 01 November 2013
View article titled, Abstract A212: Next generation sequencing (NGS) in 57 patients with advanced or metastatic breast cancer: Identification of unique genomic profiles and correlation with response.
Journal Articles

Safety, Pharmacokinetics, and Activity of GRN1005, a Novel Conjugate of Angiopep-2, a Peptide Facilitating Brain Penetration, and Paclitaxel, in Patients with Advanced Solid Tumors

Razelle Kurzrock, Nash Gabrail, Chandtip Chandhasin, Stacy Moulder, Carrie Smith, Andrew Brenner, Kamalesh Sankhala, Alain Mita, Kelly Elian, Danielle Bouchard, John Sarantopoulos
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2012) 11 (2): 308–316.
https://doi.org/10.1158/1535-7163.MCT-11-0566
Published: 08 February 2012
View article titled, Safety, Pharmacokinetics, and Activity of GRN1005, a Novel Conjugate of Angiopep-2, a Peptide Facilitating Brain Penetration, and Paclitaxel, in Patients with Advanced Solid Tumors
Open the PDF for Safety, Pharmacokinetics, and Activity of GRN1005, a Novel Conjugate of Angiopep-2, a Peptide Facilitating Brain Penetration, and Paclitaxel, in Patients with Advanced Solid Tumors in another window
Journal Articles

Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients with Advanced Malignancies: A Phase I Clinical Trial

Apostolia-Maria Tsimberidou, Chris H.M. Takimoto, Stacy Moulder, Cynthia Uehara, Monica Mita, Alain Mita, Patrick Urban, Eugene Tan, Yanfeng Wang, David Vining, Razelle Kurzrock
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (1): 209–217.
https://doi.org/10.1158/1535-7163.MCT-10-0774
Published: 10 January 2011
View article titled, Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients with Advanced Malignancies: A Phase I Clinical Trial
Open the PDF for Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients with Advanced Malignancies: A Phase I Clinical Trial in another window
Journal Articles

Development of Candidate Genomic Markers to Select Breast Cancer Patients for Dasatinib Therapy

Stacy Moulder, Kai Yan, Fei Huang, Kenneth R. Hess, Cornelia Liedtke, Feng Lin, Christos Hatzis, Gabriel N. Hortobagyi, W. Fraser Symmans, Lajos Pusztai
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2010) 9 (5): 1120–1127.
https://doi.org/10.1158/1535-7163.MCT-09-1117
Published: 09 May 2010
View article titled, Development of Candidate Genomic Markers to Select Breast Cancer Patients for Dasatinib Therapy
Open the PDF for Development of Candidate Genomic Markers to Select Breast Cancer Patients for Dasatinib Therapy in another window
Includes: Supplementary data
Journal Articles

Abstract B168: ANG1005: Results of a phase I study in patients with advanced solid tumors and metastatic brain cancer

Razelle Kurzrock, Nash Gabrail, Stacy Moulder, Cherie Noles, Carrie Smith, Zhong Guo, Danielle Bouchard, Wendy Churchill, Paula Bento, Ann Neale, Jean‐Paul Castaigne, John Sarantopoulos
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): B168.
https://doi.org/10.1158/1535-7163.TARG-09-B168
Published: 10 December 2009
View article titled, Abstract B168: ANG1005: Results of a phase I study in patients with advanced solid tumors and metastatic brain cancer
Journal Articles

Phase I dose escalation study of sodium stibogluconate (SSG), a protein tyrosine phosphatase inhibitor, in combination with interferon-α for patients with solid tumors

Luis Camacho, Aung Naing, Claire Verschraegen, Funda Meric-Bernstam, David Hong, Stacy Moulder, Cataliner Gutierrez, Saneese Stephen, Chandtip Chandhasin, Hui Gao, Evans Cohen, Bang-Ning Lee, Maritza Martinez, Lawrence Akinsanmi, Razelle Kurzrock, James Reuben
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): B89.
Published: 01 November 2007
View article titled, Phase I dose escalation study of sodium stibogluconate (SSG), a protein tyrosine phosphatase inhibitor, in combination with interferon-α for patients with solid tumors